LGND

Q: What is the price of Ligand Pharmaceuticals (LGND) today?

The current price of Ligand Pharmaceuticals (LGND) is $ 227.44, representing a 108.37% gain over the past year. The stock began the year trading around $ 189.07 and is currently priced at $ 227.44. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Ligand Pharmaceuticals (LGND) pay dividends?

Ligand Pharmaceuticals (LGND) did not pay dividends over the past year.

Ligand Pharmaceuticals Incorporated

Price

$ 227.44

return (12m)

108.37%

p/e

35.31

p/bv

4.32

DIVIDEND YIELD

0.00%

LGND price

LGND

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment LGND

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

13.94%

3 months

18.40%

1 year

108.37%

2 years

218.45%

5 years

56.67%

10 years

89.00%

Fundamentals LGND

review the fundamentals of Ligand Pharmaceuticals shares

P/E

35.31

Sector: -4.05 Industry: -4.05

P/S (PSR)

16.39

Sector: -3.86 Industry: -3.86

P/BV

4.32

Sector: 1.89 Industry: 1.89

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

7.97%

Sector: -61.23% Industry: -61.23%

ROE

12.23%

Sector: -60.44% Industry: -60.44%

ROIC

8.16%

Sector: -1,165.26% Industry: -1,165.26%

NET MARGIN

46.42%

Sector: -39.16% Industry: -39.16%

GROSS MARGIN

94.57%

Sector: 37.91% Industry: 37.91%

OPERATING MARGIN

17.61%

Sector: -39.32% Industry: -39.32%

EV/EBITDA

37.06

Sector: -3.92 Industry: -3.92

EV/EBIT

51.26

Sector: -4.14 Industry: -4.14

PRICE-TO-ASSETS

2.82

Sector: 1.41 Industry: 1.41

BVPS

53.54

Sector: 1.88 Industry: 1.88

EPS

6.55

Sector: -2.05 Industry: -2.05

EQUITY-TO-ASSETS RATIO

0.65

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.35

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

-0.66%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

16.66%

Sector: - Industry: -

FAIR VALUE OF Ligand Pharmaceuticals ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 227.44

Fair Value

$ 0.00

Upside/Downside Return potential.

-60.94%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals LGND

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	26.05	6.75	25.92%	2.29%	$ 548.05 B	21.83%
PFE	19.76	1.65	8.35%	6.37%	$ 153.52 B	12.42%
ABBV	83.09	0.00	0.00%	3.35%	$ 351.12 B	6.91%
NVO	11.67	6.01	51.50%	4.53%	$ 182.84 B	33.05%
MRK	15.22	0.00	0.00%	2.97%	$ 277.74 B	28.08%
AZN	28.78	6.04	20.99%	1.69%	$ 294.30 B	17.41%
GILD	19.03	7.16	37.62%	2.45%	$ 161.96 B	28.90%
BMY	16.77	-3.48	-20.72%	4.28%	$ 118.31 B	14.64%
ZTS	19.15	15.37	80.25%	1.74%	$ 51.19 B	28.23%
REGN	17.18	2.48	14.41%	0.48%	$ 77.41 B	31.41%
HALO	24.34	158.01	649.21%	0.00%	$ 7.71 B	22.69%
AMGN	24.08	21.45	89.06%	2.80%	$ 185.71 B	20.98%
MCK	23.47	-1,028.86	-4,383.84%	0.38%	$ 101.86 B	1.09%
VRTX	27.65	5.86	21.18%	0.00%	$ 109.29 B	32.94%
HRMY	11.06	2.02	18.24%	0.00%	$ 1.76 B	18.27%
CAH	28.38	-17.47	-61.56%	1.02%	$ 47.16 B	0.68%
ADMA	18.24	5.61	30.78%	0.00%	$ 2.68 B	28.80%
BIIB	20.96	1.48	7.08%	0.00%	$ 27.10 B	13.07%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

LGND Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	04/05/2007	04/19/2007	15,00000000

ABOUT Ligand Pharmaceuticals

Ligand Pharmaceuticals Incorporated

Average Investor10 user rating

4.0 (0 people)

United States

39 years

Founded: 1987

1995

Time since IPO - 31 years

115

Employees

Ligand Pharmaceuticals Incorporated (United States) is listed on the Nasdaq and has a market capitalization of $4.39 Billions, with shareholders equity totaling $1.02 Billion.

The company employs approximately 115 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Ligand Pharmaceuticals Incorporated reported $268.09 Millions in revenue, generating net income of $124.45 Millions.

Key financial metrics include a P/E ratio of 35.31, a price-to-book (P/B) ratio of 4.32, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker LGND.

Market cap

$ 4.39 Billions

Net worth

$ 1.02 Billion

$ 1,017,210,000.00

Assets

$ 1.56 Billion

$ 1,560,640,000.00

Total Shares Outstanding

19.00 Millions

19,000,000

Average Daily Trading Volume

$ 220.71 Thousand

$ 220,706.00

Sector

Health Care

Industry

Biotechnology

LGND

LGND revenue and profits

Financial Results LGND

DRAG THE FRAME TO SEE MORE DATA

LGND cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 814.02 15,48% (12M)

P/E

23.47

0.38%

ROE

-4,383.84%

P/BV

-1,028.86

CAH - Cardinal Health

$ 195.24 32,04% (12M)

P/E

28.38

1.02%

ROE

-61.56%

P/BV

-17.47

JNJ - Johnson & Johnson

$ 227.19 50,46% (12M)

P/E

26.05

2.29%

ROE

25.92%

P/BV

6.75

PFE - Pfizer

$ 26.33 18,59% (12M)

P/E

19.76

6.37%

ROE

8.35%

P/BV

1.65

ABBV - AbbVie

$ 206.60 8,40% (12M)

P/E

83.09

3.35%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 112.16 39,74% (12M)

P/E

15.22

2.97%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 184.74 30,42% (12M)

P/E

28.78

1.69%

ROE

20.99%

P/BV

6.04

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 814.02 15,48% (12 M)

P/L

23.47

0.38%

ROE

-4,383.84%

P/VP

-1,028.86

CAH - Cardinal Health

$ 195.24 32,04% (12 M)

P/L

28.38

1.02%

ROE

-61.56%

P/VP

-17.47

JNJ - Johnson & Johnson

$ 227.19 50,46% (12 M)

P/L

26.05

2.29%

ROE

25.92%

P/VP

6.75

PFE - Pfizer

$ 26.33 18,59% (12 M)

P/L

19.76

6.37%

ROE

8.35%

P/VP

1.65

ABBV - AbbVie

$ 206.60 8,40% (12 M)

P/L

83.09

3.35%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 112.16 39,74% (12 M)

P/L

15.22

2.97%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 184.74 30,42% (12 M)

P/L

28.78

1.69%

ROE

20.99%

P/VP

6.04

Frequently Asked Questions

What is the price of Ligand Pharmaceuticals (LGND) today?

The current price of Ligand Pharmaceuticals (LGND) is $ 227.44, representing a 108.37% gain over the past year. The stock began the year trading around $ 189.07 and is currently priced at $ 227.44. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Ligand Pharmaceuticals (LGND) pay dividends?

Ligand Pharmaceuticals (LGND) did not pay dividends over the past year.

Is Ligand Pharmaceuticals (LGND) a good investment?

Ligand Pharmaceuticals (LGND) is currently trading at $ 227.44 with a P/E ratio of 35.31%. This represents a -11,100% premium compared to its historical average P/E. Over the past year, the stock has gained 108.37 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 108.37%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Ligand Pharmaceuticals (LGND) stock?

You can buy Ligand Pharmaceuticals (LGND) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol LGND and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Ligand Pharmaceuticals (LGND) yield today?

Over the past month, Ligand Pharmaceuticals (LGND) has returned 13.94% — 108.37% over the past year, and 56.67% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Ligand Pharmaceuticals (LGND) today at the current price of $ 227.44 your total investment would be $ 22,744.00.

Based on historical performance, the investment would have grown to approximately:

$ 47,391.67 after 1 year
$ 35,633.02 after 5 years
$ 42,986.16 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

LGND

Ligand Pharmaceuticals Incorporated

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment LGND

review the fundamentals of Ligand Pharmaceuticals shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

current DY: 0.00%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT Ligand Pharmaceuticals

Ligand Pharmaceuticals Incorporated

United States

39 years

1995

115

PROFIT X PRICE LGND

Financial Results LGND

LGND cash flow

Asset, Revenue and Profit Growth - LGND

LGND balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions